510(k) device
Brainlab Elements Guide XT, Guide 3.0
Brainlab AG · Brain Stimulation Programming Planning Software. (QQC, Class II) · First FDA decision Apr 19, 2022, newest Apr 19, 2022Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Brainlab Elements"
MAUDE reports
7
Brand "Brainlab Elements", since 2015
PubMed studies
59
Mentioning "Brainlab Elements"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Brainlab Elements Guide XT, Guide 3.0
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K213930 · Decided Apr 19, 2022 · 124 days after receipt
Device type: Brain Stimulation Programming Planning Software. (QQC) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Deep Brain Stimulation for Essential Tremor and Parkinson’s DiseaseNational determinationOn the books160.24Updated Nov 4, 2026
- Deep Brain Stimulation for Parkinson's DiseaseNational analysisReview closedCAG-00124NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Brainlab Elements", any status and sponsor, newest update first.
- Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar ProgrammingNot yet recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauAcademic, hospital or other
NCT07369310 · 20 participants (planned) · Start Mar 1, 2026 · Primary completion Mar 1, 2028
Device: Conventional DBS Programming (Monopolar Review); Objective-Guided DBS Programming (Imaging and Local Field Potential-Based) · For: Parkinson's Disease; Parkinson; Parkinsons Disease (PD) and 3 more
Sites: Barcelona, Spain
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Brainlab Elements", and for the whole product code for context.
This brand
7 reports: 0 malfunction, 7 injury, 0 death
Whole product code QQC
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
8043933-2026-00043 · Received Jul 3, 2026 · Event dated May 28, 2026
Device type: System, Image Processing, Radiological (LLZ)
Device problem as coded: Use of Device Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Brainlab Elements"[tiab]. The summary above synthesizes these.
- Usability of mixed reality in awake craniotomy planning.
Moon RDC, Barua NU · Br J Neurosurg · 2024
- A dosimetric comparative analysis of Brainlab elements and Eclipse RapidArc for spine SBRT treatment planning.
Deshazer G, Narayanasamy G, Bimali M, et al. · Biomed Phys Eng Express · 2022
- [Utilization of Intraoperative Navigation in Stereotactic Neurosurgery].
Fukuda M, Ota T · No Shinkei Geka · 2025Review, English Abstract
- Deep Brain Stimulation Lead Localization Variability Comparing Intraoperative MRI Versus Postoperative Computed Tomography.
Yearley AG, Chua M, Horn A, et al. · Oper Neurosurg · 2023Research Support, N.I.H., Extramural
- Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT.
Retif P, Djibo Sidikou A, Mathis C, et al. · Strahlenther Onkol · 2022
- A comprehensive evaluation of advanced dose calculation algorithms for brain stereotactic radiosurgery.
Yoon J, Jung H, Tanny SM, et al. · J Appl Clin Med Phys · 2023
- Evaluation of PTV margins and plan robustness for single isocentre multiple target stereotactic radiosurgery.
Lam CHM, Bernstein D, Wells E · Phys Med · 2023
- Cranial volume measurement with artificial intelligence and cognitive scales in patients with clinically isolated syndrome.
Albuz Ö, Acir I, Haşimoğlu O, et al. · Front Neurol · 2024
- Quantitative analysis of intracranial and intraorbital volume changes following craniosynostosis surgery: a retrospective imaging study.
John J, Konar S, Shukla D, et al. · Childs Nerv Syst · 2025Observational Study, Research Support, Non-U.S. Gov't
- Subthalamic segmentations in relation to deep brain stimulation volumes in Parkinson's disease.
Calvano A, Xiao Y, Steidel K, et al. · Acta Neurochir (Wien) · 2026Research Support, Non-U.S. Gov't
- Benchmarking Tests of Contemporary SRS Platforms: Have Technological Developments Resulted in Improved Treatment Plan Quality?
Paddick I, Mott J, Bedford J, et al. · Pract Radiat Oncol · 2023
- Symmetry recovery in zygomaticomaxillary complex fractures compared to normal unfractured population: A new reliable 3D evaluation.
Dubron K, Yang LH, Jacobs R, et al. · J Stomatol Oral Maxillofac Surg · 2024Comparative Study
Other devices of this type
Also filed under product code QQC.
- Bullsai ConfirmTuring Medical Technologies, Inc. · 510(k) 2025
- SureTune4 SoftwareMedtronic Neuromodulation · De Novo 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.